$PIII

P3 Health Partners Inc.

P3 Health Partners is a patient-centered, physician-led population health management company focused on value-based care, primarily for Medicare Advantage members. It partners mainly with local physician groups and independent physicians through an affiliate model, supporting them with care teams, technology, patient risk management and clinical programs while allowing them to remain independent. P3 also augments its network with employed primary care physicians, operated clinics and wellness centers, and provides delegated services including networking, credentialing, utilization management and claims processing. P3 contracts with health plans to provide capitated care services, receiving per-member-per-month payments and sharing in savings associated with managing care costs. Its proprietary P3 Technology/Health Hub includes the Provider Portal, P3 Care Connect and Analytic Management Tools. As of December 31, 2025, P3 has contracted with 2,400 primary care physicians and operates in Arizona, California, Nevada and Oregon. P3 Health Partners is headquartered in Chicago, Illinois.

1
0
0

No SEC Form 4 filings for $PIII in the last 30 days.

See all $PIII insider activity →
Med

P3 Health Partners earnings beat by $4.86, revenue topped estimates

P3 Health Partners (PIII) reported Q3 EPS of $0.07, beating estimates by $4.86, with revenue of $396.34M, exceeding expectations. The company forecasts FY 2026 revenue between $1.53B-$1.6B. The stock is down 61.2% over the last 3 months and 43.33% over the past year.

P3 Health Partners Announces Third Quarter 2026 Results

P3 Health Partners Inc. (PIII) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 P3 Health Partners Announces Third Quarter 2026 Results Adjusted EBITDA of $21 Million for the Third Quarter and $101 Million Year-to-Date Raises Full-Year 2026 Adjusted EBITDA Guidance Midpoint Management to Host Conference Call and Webcast November 9, 2026 at 4:30

P3 Health Partners Inc. (PIII): Entry into a Material Definitive Agreement

P3 Health Partners Inc. (PIII) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement Item 3.02 Unregistered Sales of Equity Securities Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On September 8, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase

PIII sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning PIII (P3 Health Partners Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent PIII coverage spans earnings, corporate actions and insider activity.

What's driving PIII

AlphAI scores every news story that mentions PIII with an AI model for sentiment and relevance, and aggregates insider trades from P3 Health Partners Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $PIII

Score
$PIIIMedEarnings

P3 Health Partners Announces Third Quarter 2026 Results

P3 Health Partners Inc. (PIII) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 P3 Health Partners Announces Third Quarter 2026 Results Adjusted EBITDA of $21 Million for the Third Quarter and $101 Million Year-to-Date Raises Full-Year 2026 Adjusted EBITDA Guidance Midpoint Management to Host Conference Call and Webcast November 9, 2026 at 4:30

$PIIIHighOffering· $70M · proposed

P3 Health Partners Inc. (PIII): Entry into a Material Definitive Agreement

P3 Health Partners Inc. (PIII) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement Item 3.02 Unregistered Sales of Equity Securities Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On September 8, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase

$PIIIMedAI 9/10

P3 Health Partners (PIII) Q2 2026 Earnings Call Transcript

P3 Health Partners (PIII) reported Q2 2026 adjusted EBITDA of $54.4 million versus a prior-year loss, on total revenue of $386.4 million (+9% YoY). At-risk membership fell 10% to 105,000. Net income was $15.7 million. The company raised full-year 2026 guidance to adjusted EBITDA of $80 million to $110 million and revenue of $1.5 billion to $1.6 billion.

$PIIIHighEarnings

P3 Health Partners Announces Second Quarter 2026 Results

P3 Health Partners Inc. (PIII) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 P3 Health Partners Announces Second Quarter 2026 Results Raises Full-Year 2026 Adjusted EBITDA Guidance Management to Host Conference Call and Webcast August 10, 2026 at 4:30 PM ET HENDERSON, NV—August 10, 2026—P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ:

$PIIIMedDebt financing· 14%

P3 Health Partners Inc. (PIII): Entry into a Material Definitive Agreement

P3 Health Partners Inc. (PIII) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. piii-20260630 0001832511 false 0001832511 2026-06-30 2026-06-30 0001832511 us-gaap:CommonClassAMember 2026-06-30 2026-06-30 0001832511 us-gaap:WarrantMember 2026-06-30 2026-06-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSU

$PIIILowShareholder vote

P3 Health Partners Inc. (PIII): Submission of Matters to a Vote of Security Holders

P3 Health Partners Inc. (PIII) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. piii-20260609 0001832511 false 0001832511 2026-06-09 2026-06-09 0001832511 us-gaap:CommonClassAMember 2026-06-09 2026-06-09 0001832511 us-gaap:WarrantMember 2026-06-09 2026-06-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSU

Short Interest in P3 Health Partners Inc. (NASDAQ:PIII) Rises By 293.3%

P3 Health Partners (NASDAQ:PIII) reported short interest of 283,541 shares as of May 15, up 293.3% from 72,094 on April 30; about 4.8% of shares are sold short, with a days-to-cover ratio near 0.0. The stock fell 26% on Friday to $12.18. UBS and Lake Street set $14 targets; TD Cowen reiterated hold. The company reported Q1 EPS of $0.32 on revenue of $386.39M.

Related tickers